BSE Notices 31-12-2007

Cambridge Solutions
Cambridge Solutions Ltd has informed BSE that the members at the Extra Ordinary General Meeting (EGM) of the Company held on December 17, 2007, inter alia, have accorded the Board of Directors of the Company to issue, offer and allot Global Depository Receipts / American Depository Receipts or Foreign Currency Convertible Bonds up to an aggregate sum of US $ 40 million including a green shoe option of USD 10 million in international markets inclusive of such premium directly to Foreign / Non-resident investors (whether institutions, incorporated bodies, mutual fund, Trust / Foreign Institutional Investors / Bank and / or individuals) through Private Placement(s) or Public issue(s) or a combination thereof at such time or times in such tranche or tranches, at such price or prices in such manner and on such terms and conditions as may be decided and deemed appropriate by the Board / Committee at the time of such issue or allot considering the prevailing market conditions and other relevant factors, wherever necessary in consultation with the lead managers / Underwriters, in any markets as may be deemed fit by the Board, so as to enable the Company to get listed at any stock exchanges in Luxemburg / Singapore / London / Nasdaq / New York Stock Exchanges and / or any of the Overseas Stock Exchanges, subject to necessary provisions & approvals.
Source: BSE Date: 2007-12-31

NEPC India
NEPC India Ltd has informed BSE that the members at the Extra Ordinary General Meeting (EGM) of the Company held on December 24, 2007, have accorded for the increase of the authorised Share Capital of the Company from Rs 150,00,00,000/- (Rupees One Hundred and fifty crores only) divided as 14,00,00,000 (Fourteen Crores) Equity Shares of Rs 10/- (Rupees Ten) each and 1,00,00,000 (One Crore) Redeemable Preference Share of Rs 10/- (Rupees Ten) each with the rights, privileges and conditions attached thereto as provided by the provisions of the Companies Act, 1956 to Rs 500,00,00,000/- (Rupees Five Hundred Crores only) divided into 45,00,00,000 (Forty Five Crores) Equity Shares of Rs 10/- (Rupees Ten) each and 5,00,00,000 (Five Crores) Redeemable Preference Shares of Rs 10/- (Rupees Ten) each with rights, privileges and conditions attached thereto as provided by the provisions of the Companies Act, 1956 and regulations of the Company & consequential amendments in the Memorandum & Articles of Association of the Company.
Source: BSE Date: 2007-12-31

Vivimed Labs
Vivimed Labs Ltd has informed BSE that the members at the 19th Annual General Meeting (AGM) of the Company held on December 27, 2007, inter alia, have unanimously approved the following resolutions: 1. Adjournment of the meeting to January 21, 2008 for adoption of the Consolidated Balance Sheet as on March 31, 2007 and Profit and Loss Account and the Auditors report thereon. 2. Re-appointment of Directors retiring on rotation. 3. Re-appointment of M/s. P Murali & co., Chartered Accountants, Hyderabad as Auditors of the Company. 4. Offer, issue and allot 1880000 Convertible Warrants to promoters and persons other than promoters. 5. Increase in remuneration of Directors as per the AGM Notice. 6. Increase in borrowing powers to the Board of Directors which shall not exceed in aggregate of Rs 500 Crores (Rupees Five Hundred Crores) over and above the aggregate of Paid Up Capital and Free Reserves of the Company.
Source: BSE Date: 2007-12-31

Southern Online Bio Technologies Ltd
Southern Online Bio Technologies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on December 29, 2007, inter alia, to transact the following items of businesses and unanimously passed the following resolutions relating thereto: 1. Issue of shares under Qualified Institutional Placement: (QIP) The Board has approved, subject to approval of the Shareholders at the EGM, to raise an amount up to Rs 1921.50 Lakhs by way of Qualified Institutional Placement (QIP) of equity shares to Qualified Institutional Buyers at a price not less than the price arrived at in pursuance of Chapter XIIIA of SEBI (DIP) Guidelines. 2. Preferential Issue: The Board has approved, subject to approval of the Shareholders at the EGM, preferential issue of 26.50 lakh warrants convertible into Equity shares to promoters and non-promoters at a price of Rs 42.70/- per share (including premium of Rs 32.70/- per share) and preferential issue of up to 24 lakh equity shares to entities / persons other than promoters / promoter group at Rs 42.70/- per share (including premium of Rs 32.70/- per share) in pursuance of Chapter XIII of SEBI (DIP) Guidelines. 3. The convening of the Extraordinary General Meeting of the Company on January 28, 2008 to approve: (i) The QIP up to Rs 1921.50 lakhs in pursuance of Chapter XIIIA of SEBI (DIP) Guidelines and (ii) The preferential issue of 26.50 lakh warrants convertible into equity shares to promoters and non-promoters and preferential issue of up to 24 lakh equity shares to entities / persons other than promoters / promoter group in pursuance of Chapter XIII of SEBI (DIP) Guidelines. 4. Approved the Draft Notice convening the EGM and Authorised to dispatch the same.
Source: BSE Date: 2007-12-31

Emco
Emco Ltd has informed BSE that the Compensation (ESOP) Committee of Directors of the Company at its meeting held on December 31, 2007, has granted 2000 stock options covering right to apply for equal number of Equity Shares of the Company i.e. each option carrying right to apply for one Equity share of the Company, to an employees of the Company. Against each such option, the employee will have right to apply for and get allotted one equity share at a exercise price of Rs 1510/- (Rupees One Thousand Five Hundred Ten Only). The vesting period for the said options is in graded manner within the period from respective grant and as prescribed in grant letters, subject to minimum vesting period of one year.
Source: BSE Date: 2007-12-31

Coromandel Cements Ltd
Ckoramaandel Cements Ltd has informed BSE that the members at the Annual General Meeting (AGM) of the Company held on December 31, 2007, inter alia, have resolved the following: 1. The meeting has Considered, approved and adopted by way of Ordinary Resolution, the Audited Profit and Loss Account for the period September 30, 2007 (18 Months) and Balance Sheet and Cash Flow statement as on that date together with Directors’ and Auditors’ Report. 2. The meeting has approved by way of Ordinary Resolution the appointment of M/s. A Ramachandra Rao & Co., Chartered Accountants, as auditors from the Conclusion of this annual General Meeting until the conclusion of the next Annual General Meeting. 3. The meeting has approved by way of Ordinary Resolution the re-appointment of Sri. K R Chari Director retire by rotation and being eligible, offers himself for re-appointment. 4. The meeting has approved by a Special Resolution, issue of Bonus Shares to the Shareholders of the Company in proportion of 7:4 shares held by the shareholders on the record date to be decided by the Board.
Source: BSE Date: 2007-12-31

Pudumjee Agro Industries
Pudumjee Agro Industries Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 08, 2008, inter alia, to consider the sub-division of face value of equity shares and also change in the name of the Company.
Source: BSE Date: 2007-12-31

Sarla Gems
Sarla Gems Ltd has informed BSE with respect to petition presented to Hon’ble High Court at Calcutta dated December 04, 2007 to confirmed reduction of capital of the Company from Rs 4,53,70,000/— to Rs 2,26,85,000/- by canceling a sum of Rs 5/- against every paid up equity share of Rs 10/- each and consolidating two equity shares paid up to the extent of Rs 5/- each into one equity share of Rs 10/- each fully paid up which sum has been lost and are unrepresented by the available assets, will be heard before the Hon’ble Judge taking Company Matters on January 07, 2008.
Source: BSE Date: 2007-12-31

Midland Polymers Ltd
State Bank of India (SBI) the Operating Agency (OA) has informed BSE that the meeting of stake holders of Midland Polymers Ltd was held on December 18, 2007 to discuss the proposed Draft Rehabilitation Scheme (DRS), as per the BIFR directives. The State Bank of India is now finalizing the DRS for onward submission to BIFR.
Source: BSE Date: 2007-12-31

Bilpower
Bilpower Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 07, 2008, inter alia, to transact, with or without modifications the following business: 1. To discuss and adopt Un-audited Financial Results for the Quarter / Nine months ended December 31, 2007. 2. To discuss the status of issuance of “Foreign Currency Convertible Bonds (FCCBs)”. 3. To discuss and approve the Issue of upto 20,00,000 (Twenty Lacs) Convertible Warrants to Promoters and / or others on Preferential Basis, which shall be convertible into Equity Shares of a face value of Rs 10/- each at a conversion price of Rs 350/- (Three Hundred Fifty only) within 18 months, subject to necessary approval of the Shareholders of the Company and all other statutory authorities, if any. 4. To decide date, venue and time of Extra Ordinary General Meeting.
Source: BSE Date: 2007-12-31

Ambuja Cements
Ambuja Cements Ltd has informed BSE that the Share Allotment & Investor Grievance Committee at its meeting held on December 31, 2007 has allotted 178,563 Equity Shares on exercise of the stock options by the employees as per the details given below: 1. ESOS 2002-2003 : 1,125 shares allotted 4. ESOS 2003-2004 : 18,000 shares allotted 5. ESOS 2004-2005 : 74,063 shares allotted 6. ESOS 2005-2006 : 85,375 shares allotted.
Source: BSE Date: 2007-12-31

Arrow Coated Products
Arrow Coated Products Ltd has informed BSE that the members at the 15th Annual General Meeting (AGM) of the Company held on December 29, 2007, inter alia, have accorded the following: 1. Adoption of the Profit and Loss Account for the year ended March 31, 2007, the Balance Sheet as at that date, the Report of the Directors and Auditor’s of the Company. 2. For declaration of Dividend for the Year ended March 31, 2007 be and is hereby withdrawn. 3. Re-appointment of Mr. Vijay Dhar & Mr. Haresh Mehta as Directors of the Company. 4. Re-appointment of M/s. J A Rajani & Company, Chartered Accountants, as Auditors of the Company to hold office from the conclusion of this Meeting until the conclusion of next Annual General Meeting of the Company , on remuneration, terms & conditions. 5. Appointment of Mr. R Somashekar as a Director of the Company, liable to retire by rotation. 6. Appointment of Mr. R Somashekar as Whole Time Director of the Company for a period of three years with effect from October 04, 2007, on remuneration, terms & conditions. 7. Re-appointment of Mr. Shilpan Patel as Managing Director of the Company for a period of three years with effect from December 01, 2007, on remunerations, terms & conditions. 8. Re-appointment of Mr. Mukesh Patel as Whole Time Director of the Company for a period of three years with effect from May 01, 2008, on remunerations, terms & conditions. 9. Amendments in Arrow Coated Products Ltd Employee Stock Option Scheme 2007 of the Company.
Source: BSE Date: 2007-12-31

Housing Development Finance Corporation
Housing Development Finance Corporation Ltd (HDFC) has informed BSE that during the last week the Corporation received Conversion Notices for conversion of 144 FCCBs of the face value of USD 100000 each. Accordingly the Corporation on December 31, 2007, allotted 4,49,963 equity shares of Rs 10 each in terms of the Offering Circular dated September 21, 2005. Post the above allotment, the paid-up equity share capital of the Corporation would stand at Rs 281,57,00,390 consisting of 28,15,70,039 equity shares of Rs 10 each. The summary of the FCCBs converted till date is as follows: - Total FCCBs issued (Face Value USD 100000): 5000 - Number of FCCBs converted till date: 3305 - %ge converted: 66.10%.
Source: BSE Date: 2007-12-31

Parekh Aluminex
Parekh Aluminex Ltd has informed BSE that the members at the 7th Extra Ordinary General Meeting (EGM) of the Company held on December 29, 2007, inter alia, have approved the following resolutions: 1. Increase in Authorised Capital from Rs 16 crores to Rs 20 crores. 2. Alternation of Capital Clause of the Memorandum of Association to incorporate the increased authorised capital of the Company from Rs 16 crores to Rs 20 crores. 3. Alternation of Capital Clause of the Articles of Association to incorporate the increased authorised capital of the Company Rs 16 crores to Rs 20 crores. 4. Increase of Investment limit of Foreign Institutional Investors from 49% to upto 74% of the paid up share capital of the Company. 5. Delisting of shares of the Company from Pune Stock Exchange. 6. Preferential allotment up to 31,50,000 Equity shares to investors at a price of Rs 260/- including premium of Rs 250/- per Equity Share.
Source: BSE Date: 2007-12-31

Mudra Lifestyle
Mudra Lifestyle Ltd has informed BSE that the members at the Extra Ordinary General Meeting (EGM) of the Company held on January 18, 2008, inter alia, to transact the following business: 1. To create, offer, issue and allot up to 30,00,000 Equity Warrants, entitling the warrant holder(s) from time to time to apply for equity share of the Company in one or more tranch(es), within an aggregate time period of 18 months from the date of allotment of the warrants, to promoters / strategic investors, whether or not they are members of the Company, on preferential placement basis, through offer letter and / or circular and / or information memorandum and / or private placement memorandum and / or such other documents / writings, in such manner and on such terms and conditions as may be determined by the Board in its absolute direction, provided that the aggregate number of resultant equity shares of the Company to be issued against such warrants shall not exceed 30,00,000 (Thirty Lakhs) fully paid equity shares of the face value of Rs 10 each at a price not less than the higher of the following: a. The average of the weekly high and low of the closing prices of the Company’s shares quoted on the stock exchange (Bombay Stock Exchange Ltd) during the six months preceding the relevant date’ or b. The average of the weekly high and low of the closing prices of the Company’s shares quoted on a stock exchange (Bombay Stock Exchange Ltd) during the two weeks preceding the ‘relevant date’. The ‘relevant date’ for this purpose being December 19, 2007. 2. To issue, offer and allot, in the course of international offerings, in one or more foreign markets, equity shares / preference shares / convertible debentures / Convertible Notes / Foreign Currency Convertible Bonds (FCCBs) / Secured Premium Notes (SPN) and / or any securities convertible into equity shares at the option of the Company and / or holder of the securities and / or securities linked to equity shares through American Depository Receipts (ADRs) and / or Global Depository Receipts (GDRs) and / or any other instruments or securities (”Securities”) subscribed to in foreign currency(ies) for cash or stock swap or for other valuable consideration including strategic alliances, business(es) or a combination thereof, to Foreign Investors (whether Institutions and / or Incorporated Bodies and / or Individuals and whether or not such investors are members of the Company) through Public Issue(s), Private Placement(s), Preferential Allotment(s), which upon conversion of all Securities so issued or allotted could give rise to the issue of an amount (inclusive of such premium as may be determined) up to Rs 200 Cr and such issue and allotment to be made at such time or times, in one or more tranches, at such price or prices, on such terms and conditions including security, rate of interest and In such manner as the Board may, in its absolute discretion think fit in consultation with the Lead Manager(s) / Investment Banker(s) and / or the Underwriters, subject to guidelines of the Reserve Bank of India(RBI), Securities and Exchange Board of India(SEBI) and Ministry of Finance, and otherwise on such terms and conditions as may be decided and deemed appropriate by the Board at the time of issue or allotment, subject to necessary provisions & approvals. 3. To increase the Authorised Share Capital of the Company is Rs 40,01,00,000 (Rupees Forty Crores One Lac) divided into 4,00,10,000 (Four Crores Ten thousand only) equity shares of Rs 10 (Rupees ten) to Rs 60,01,00,000 (Rupees Sixty Crores One Lac only) divided into 6,00,10,000 ( Six Crores Ten thousand) equity shares of Rs 10 (Rupees ten) each and consequential amendment in the Memorandum of Association of the Company. 4. To borrow any sum or sums of money (including non fund based facilities) from time to time at their discretion, for the purpose of the business of the Company, from any one or more Banks, Financial Institutions and other persons, firms, bodies corporate, notwithstanding that the monies to be borrowed together with the monies already borrowed by the Company (apart from temporary loans obtained from the Company’s Bankers in the ordinary course of business) may, at any time, not exceeding, upto a sum of Rs 500 Crores (Rupees Five hundred Crores) over and above the aggregate of the then paid up capital of the Company and its free reserves (that is to say reserves not set apart for any specific purpose) and that the Board of Directors be and is hereby empowered and authorised to arrange or fix the terms and conditions of all such monies to be borrowed from time to time as to interest, repayment, security or otherwise as they may, in their absolute discretion, think fit, subject to necessary provisions & approvals.
Source: BSE Date: 2007-12-31

Dolat Investments
Dolat Investments Ltd has informed BSE that the members of the Company, by way of Postal Ballot, have passed the Special Resolution with requisite majority, for the shifting the Registered Office of the Company from the State of Maharashtra to the State of Tamil Nadu, subject to confirmation of the Company Law Board the existing Clause II of the Memorandum of Association of the Company.
Source: BSE Date: 2007-12-31

Hindustan Organic Chemicals
Hindustan Organic Chemicals Ltd has informed BSE that the Company has issued an advertisement in the leading International Technical Journal inviting for Expression of Interest for Joint Venture Projects with the Company by various Corporate Multi National Companies.
Source: BSE Date: 2007-12-31

Idea Cellular
Idea Cellular Ltd has informed BSE that the ESOS Compensation committee of the Company on December 31, 2007 has resolved to grant 1,99,31,000 Stock Options to the Eligible Employees (including the Managing Director) of the Company and its subsidiaries, under the “Employee Stock Option Scheme-2006″ (ESOS-2006), each option being convertible into one Equity Share of the Company upon vesting, at an exercise price of Rs 112.57 per share. Subject to the Securities and Exchange Board of India (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999 and the terms of the ESOS-2006, the options will vest in 4 equal annual installments after one year of the grant and shall be exercisable within a period of 5 years from the date of vesting.
Source: BSE Date: 2007-12-31

Idea Cellular
Idea Cellular Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 19, 2008, inter alia, to consider and take on record the Un-audited Financial Results for the third quarter ended December 31, 2007 (Q3).
Source: BSE Date: 2007-12-31

Ranbaxy Laboratories
Ranbaxy Laboratories Ltd on December 31, 2007 has announced that the Company has received final approval from the U.S. Food and Drug Administration to manufacture and market Cetirizine Hydrochloride Tablets (OTC), 5 mg and 10 mg. The Office of Generic Drugs, U.S. Food and Drug Administration, has determined the Ohm formulation to be bioequivalent and have the same therapeutic effect as that of the reference listed drug Zyrtec® Allergy tablets, 5mg and 10mg and Zyrtec® Hives Relief tablets, 5mg and 10mg by Pfizer Pharmaceuticals Inc. Total annual market sales for Cetirizine Hydrochloride Tablets as a prescription only product were $1.3 billion (IMS - MAT: September 2007). Cetirizine Hydrochloride is indicated for the temporary relief of runny nose, sneezing, itching of the nose or throat, and itchy, watery eyes due to hay fever or other upper respiratory allergies. “We are pleased to receive this final approval for Cetirizine Hydrochloride Tablets (OTC) 5mg and 10mg, that has proven its clinical value and utility in both adults and children. We are pleased to offer this preferred formulation that will meet the needs of all patients who need this medication in response to allergic reactions. This OTC product formulation further expands our portfolio of affordable generic alternatives and will be launched immediately to all classes of trade,” said Jim Meehan, Vice President of Sales and Distribution for Ohm Laboratories Inc, a wholly owned subsidiary of the Company. Ohm, based in North Brunswick, New Jersey, is a wholly owned subsidiary of the Company. Ohm is engaged in the sale and distribution of generic and branded private label, OTC products in the U.S. healthcare system.
Source: BSE Date: 2007-12-31

Euro Ceramics
Euro Ceramics Ltd has informed BSE that members of the Company, by way of Postal Ballot has passed the following resolutions, with requisite majority : 1. Special Resolution for issue of Equity Shares on preferential basis. 2. Special Resolution for issue of FCCBs / GDRs / ADRs / permissible Securities / instruments. 3. Ordinary Resolution for increase in Authorized Share Capital from Rs 20 Crores to Rs 35 Crores. 4. Ordinary Resolution for alteration of clause V of the Memorandum of Association upon increase in Authorized Share Capital from Rs 20 Crores to Rs 35 Crores. 5. Special Resolution for investment by FIIs upto 49% of Equity Share Capital of the Company. 6. Special Resolution for making investment, loan and providing guarantee or security.
Source: BSE Date: 2007-12-31

Supan Syntech
Javelin Technologies Ltd has informed BSE that the members at the Extra Ordinary General Meeting (EGM) of the Company held on December 31, 2007, inter alia, have accorded to the following: 1. Increase of the Authorized capital of the company from the existing Rs 7 Crores to Rs 12 crores Comprising of 1,20,00,000 equity share of Rs 10 each. 2. Issue of 7,00,000 equity shares of Rs 10/- each Fully paid up as below towards acquisition of 3,45,000 equity shares of Rs 10 each Fully paid held by them in LABCAL BIOMETRIC TECHNOLOGIES PVT LTD Hyderabad : (i) Mr. B Ashok Kumar : 3,50,000 No of Equity Shares of Rs 10/- each (ii) Mr. P Vinod Kumar : 3,50,000 No of Equity Shares of Rs 10/- each 3. Issue of 7,00,000 equity shares of Rs 10/- each folly paid up as follow towards full and final settlement of dues payable to the by LABCAL BIOMETRIC TECHNOLOGIES PVT LTD (i) Mr. D Jogesh : 3,50,000 No of Equity Shares of Rs 10/- each (ii) Mr. J Srinivasa Rao : 3,50,000 No of Equity Shares of Rs 10/- each 4. Issue of 47,25,000 warrants convertible into equal number of equity shares of Rs 10/- to the following persons at a price of Rs 23/- per share as per SEBI regulations on pricing of warrants : 1. Mrs. Hemamalini Namuduri : 7,00,000 Number of Warrants 2. Mrs. Pandrangi Nirmala Devi : 5,00,000 Number of Warrants 3. M/s. A V Artinvest Pvt Ltd : 3,00,000 Number of Warrants 4. M/s. Anklikar Securities Pvt Ltd : 3,00,000 Number of Warrants 5. M/s. C-Trade Broking Pvt Ltd : 3,00,000 Number of Warrants 6. Mr. Nampally Anand Kumar : 3,50,000 Number of Warrants 7. Naveen Yelloji : 5,00,000 Number of Warrants 8. Mr. Srinivasa Reddy Bommareddy : 2,50,000 Number of Warrants 9. Mr. Lakshmi Bommareddy : 2,50,000 Number of Warrants 10. Mr. Basavaraju Sudhakar Babu : 2,50,000 Number of Warrants 11. Mr. Akella Narasimha Sarma : 2,25,000 Number of Warrants 12. Mr. Madishetty Srinivas : 2,50,000 Number of Warrants 13. Mr. Valasingam Krishna : 2,50,000 Number of Warrants 14. Mrs. Prabha Vijayvargiya : 1,00,000 Number of Warrants 15. Mr. Santosh Vijayvargiya : 1,00,000 Number of Warrants 16. Mrs. Monica Jalota : 1,00,000 Number of Warrants
Source: BSE Date: 2007-12-31

Phoenix Mills
Phoenix Mills Ltd has informed BSE that the members of the Company, by way of Postal Ballot, will consider to approve, the following resolutions: 1. To create, offer, issue, transfer and allot at any time to or to the benefit of such person(s) who are in permanent employment of the Company, including any Director of the Company, whether whole time or otherwise, options exercisable into not more than 6,78,000 (Six Lakh Seventy Eight Thousand) Equity Shares of the Company of face value Rs 10/- each, under the Scheme titled “The Phoenix Mills Employees Stock Option Plan 2007″ (”ESOP 2007″} in one or more tranches and on such terms and conditions as may be fixed or determined by the Board in accordance with the provisions of the law or guidelines issued by the relevant Authority; each option being exercisable for one Equity Share of a face value of Rs 10/- each fully paid up on payment of the requisite exercise price, subject to necessary provisions & approvals. 2. To create, offer, issue and allot at any time to or to the benefit of such person(s) who are in permanent employment of its current subsidiaries namely Bellona Finvest Ltd, Marketcity Developers Ltd, Pallazzio Hotels & Leisure Ltd, Marketcity Resources Pvt Ltd, Pinnacle Real Estate Development Pvt Ltd and Vamona Developers Pvt Ltd, and any other future subsidiaries of the Company, including any Director of the Company, whether in whole time employment or otherwise, options exercisable into shares within the overall ceiling of 6,78,000 (Six Lakh Seventy Eight Thousand) Equity Shares of the Company as mentioned in Resolution No. 1 above, under the Scheme titled “The Phoenix Mills Employees Stock Option Plan 2007 (ESOP 2007), in one or more tranches and on such terms and conditions as may be fixed or determined by the Board in accordance with the provisions of the law or guidelines issued by the relevant Authority; each option would be exercisable for one Equity Share of a face value of Rs 10 each filly paid-up on payment of the requisite exercise price, subject to necessary provisions & approvals. 3. To sub-dividend the existing Equity Share of the face value of Rs 10/- (Rupees Ten only) as comprised in the Issued and Un-issued Share Capital of the Company into 5 (Five) Equity Shares of the face value of Rs 2/- (Rupee Two only) each. Further the existing Clause V of the Memorandum of Association of the Company be and is hereby deleted and substituted by the following new Clause V: V : The Authorized Share Capital of the Company is Rs 30,00,00,000/- (Rupees Thirty Crores only) divided into 15,00,00,000 (Fifteen Crore) Equity Shares of Rs 2/- (Rupees Two only) each with rights, privileges and conditions attached thereto as are provided by the Articles of Association of the Company for the time being, with power to increase or reduce the capital of the Company and to divide the shares in the capital for the time being into several classes and to attach thereto respectively such preferential, deferred, qualified or special rights, privileges or conditions as may be determined by or in accordance with the Articles of Association of the Company and to vary, modify or abrogate any such rights, privileges or conditions in such manner as may for the time being be provided by the Articles of Association of the Company. 4. The existing Article 4 of the Articles of Association be and is hereby deleted and the following article be substituted in its place as new Article 4 as under: 4 : The Authorized Share Capital of the Company is Rs 30,00,00,000/- (Rupees Thirty Crores only) divided into 15,00,00,000 (Fifteen Crore) Equity Shares of Rs 2/- (Rupees Two only) each with power to increase and / or reduce the capital of the Company in accordance with the provisions of the act and to divide the shares in the increased capital into several classes and attach thereto respectively such preferential, qualified or special rights, privileges and conditions in such manner as may be permitted for the time being. The Company has appointed Mr. Narayan Rathi, Partner of M/s. Rathi & Associates, Company Secretaries, as Scrutinizer for conducting the Postal Ballot voting process in a fair and transparent manner. The Postal Ballot form duly completed should reach the Scrutinizer on or before January 28, 2008. After completion of the scrutiny of the Postal Ballot forms, the Scrutinizer will submit his report to the Chairman and the results of the Postal Ballot will be announced on January 31, 2008.
Source: BSE Date: 2007-12-31

Pfizer
Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on December 31, 2007 has granted its approval to the transfer to Johnson & Johnson Ltd, of the exclusive license that the Company holds in respect of the trademarks relating to Benadryl, Caladryl, Benylin and Listerine and certain assets related thereto, for a total consideration of Rs 214,85,10,000/- (Rupees Two Hundred and Fourteen Crores Eighty Five Lakhs and Ten Thousand only) and in connection therewith the execution of the Asset Transfer Agreement. The Board of Directors also granted its approval to the Company providing to Johnson & Johnson Ltd, certain transitional services and in connection therewith the execution of the Transitional Services Agreement.
Source: BSE Date: 2007-12-31

Blue Circle Services Ltd
Blue Circle Services Ltd has informed BSE that open offer under SEBI (Substantial Acquisition of Shares and Take Overs) Regulation, 1997 to acquire shares from public announced by M/s. Yash Shelters Ltd has been successfully completed. Further the Company has informed that, Shri. Biren Shah and Shri. Darshan Bhagat has been appointed as additional directors of the Company.
Source: BSE Date: 2007-12-31

SIP Industries
SIP Industries Ltd has informed BSE that the members at the 21st Annual General Meeting (AGM) of the Company held on December 31, 2007, inter alia, have accorded the following: 1. Adoption of the audited Profit & Loss Account of the Company for the financial year ended September 30, 2007 and the Balance Sheet as on that date together with the Directors Report and Auditors Report thereon. 2. Re-appointment of Mr. D Ravi as a Director of the Company, liable to retire by rotation. 3. Re-appointment of M/s. P B Vijayaraghavan & Co., Chartered Accountants as Auditors of the Company to hold office from the conclusion of this meeting till the conclusion of the next Annual General Meeting of the Company on remuneration, terms & conditions.
Source: BSE Date: 2007-12-31

Bharat Fertilizers
Bharat Fertiliser Industries Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 11, 2008, to consider Allotment of 2,50,000 Equity Share of Rs 10/- each in favor Shri. Yogendra D Patel jointly with Smt. Anjani Y Patel.
Source: BSE Date: 2007-12-31

Silicon Valley Infotech
Silicon Valley Infotech Ltd has informed BSE that an Extra ordinary General Meeting (EGM) of the members of the Company will be held on January 30, 2008, inter alia, have accorded to the Board of Directors to capitalise a sum of Rs 6,48,40,000/- out of the Company’s Share Premium Account amounting to Rs 12,08,97,000 forming part of the undistributed profits of the Company and that the said sum so capitalised be applied for issue and allotment of 6,48,40,000 Equity Shares of Re 1/- each of the Company (the Bonus Shares) in the share capital of the Company to be allotted and distributed as fully paid-up Bonus Shares to and amongst the Members who are on the Register of Members of the Company as the holders of Equity Shares in the Company on such date as may hereafter be determined by the Board of Directors of the Company (”the Board”) in the proportion of One Bonus Shares for every Two Equity Shares held by such Members respectively on that date on the footing that they become entitled to the Bonus Shares as capital and not as Income, subject to necessary provisions & approvals.
Source: BSE Date: 2007-12-31

Crystal Software Solutuions
Crystal Software Solutions Ltd has informed BSE that the Board of Directors of the Company at its meeting held on December 26, 2007, has decided to reconvene the Extra Ordinary Meeting of the Members which was scheduled on January 15, 2008, inter alia for the purpose of increasing the authorised capital of the Company, subdivision of shares and for raising of funds through shares / warrants on preferential basis since the negotiations with parties or with prospective investors are still pending for finalization.
Source: BSE Date: 2007-12-31

Silicon Valley Infotech
Silicon Valley Infotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on December 31, 2007, inter alia, has approved the issue of bonus shares in the ratio of 1 (one) Equity Shares for every 2 (two) Equity Shares held in the Company to the Members whose name appears on the records of the Company on a record date to be fixed by the Board of Directors subsequent to approval of the Members at the Extra Ordinary General Meeting scheduled to be held on January 30, 2008 for the approval of the same.
Source: BSE Date: 2007-12-31